Oncolytics Biotech (ONCY) Return on Capital Employed Growth (1y) (2011 - 2025)
Oncolytics Biotech (ONCY) Return on Capital Employed Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 2,400.00 |
| 10 | Oncolytics Biotech | 76.69 Mn | 76.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34,393.00 |
| Jun 30, 2025 | -21,179.00 |
| Dec 31, 2024 | -16,182.00 |
| Sep 30, 2024 | 10,253.00 |
| Jun 30, 2024 | 15,904.00 |
| Dec 31, 2023 | 11,399.00 |
| Sep 30, 2023 | -915.00 |
| Jun 30, 2023 | -8,384.00 |
| Mar 31, 2023 | -4,452.00 |
| Dec 31, 2022 | -5,092.00 |
| Sep 30, 2022 | -22,090.00 |
| Jun 30, 2022 | -16,074.00 |
| Mar 31, 2022 | -12,930.00 |
| Dec 31, 2021 | -13,522.00 |
| Sep 30, 2021 | 14,078.00 |
| Jun 30, 2021 | 11,583.00 |
| Sep 30, 2020 | 1,355.00 |
| Jun 30, 2020 | -4,168.00 |
| Sep 30, 2019 | -18,165.00 |
| Jun 30, 2019 | -9,683.00 |